Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Replicel Life Sciences Inc V.RP

Alternate Symbol(s):  REPCF

RepliCel Life Sciences Inc. is a Canada-based regenerative medicine company. The Company is focused on developing cell therapies for aesthetic and orthopedic conditions, including aging/sun-damaged skin, pattern baldness, and chronic tendon degeneration. The Company’s cell therapy product pipeline is comprised of RCT-01 for tendon repair, RCS-01 for skin rejuvenation, and RCH-01 for hair... see more

TSXV:RP - Post Discussion

Replicel Life Sciences Inc > Deal Or No Deal
View:
Post by Ingiboy on Jan 21, 2021 11:56am

Deal Or No Deal

Let's review the Twitter trail:

Nov. 10th
Mainpointe Binding Agreement Deal announced.

Nov. 11th
"Posted the largest 30 day % gain..."

Nov. 13th
"We look forward to sealing deal with Mainpointe....before year-end...."

Nov. 30th
"Based on how little red text...we are bullish on our chances this deal closes with plenty of days left in 2020."

Dec. 8th
"Christmas is coming but we believe a signed deal with Mainpointe is coming even sooner."

Dec. 24th
"We don't have the Mainpointe deal sitting under the tree but the wrapping is almost done...We can't imagine it's not part of our New Years celebration."

Jan. 7th
"All is going smoothly in the last stages of getting the Replicel - Mainpointe deal to signature. Some last minute due diligence items being cleared up."

Jan. 18th
" We'r very excited to get to work on the next stage of Replicel's product development program. Once this deal closes, we are ready to rock. This is what we live for. 


Wiating for the next Twitter installment.  Many things I could say here but I don't think it's necessary.
Comment by psvbruceleefc on Jan 21, 2021 12:09pm
I think I preferred the silence over this. We was due a dermal injector under the tree last year aswell 
Comment by BellEnd on Jan 21, 2021 12:39pm
This post has been removed in accordance with Community Policy
Comment by psvbruceleefc on Jan 21, 2021 12:53pm
This was from a press release in 2015   VANCOUVER, BC – July 29, 2015 – RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSX.V: RP), a clinical stage regenerative medicine company, is pleased to announce that the final design specifications of its next-generation dermal injector (RCI-02) have been locked. Prototypes for industrial and regulatory testing will now be built to prepare for an ...more  
Comment by Ingiboy on Jan 21, 2021 1:54pm
psvbruceleefc maybe now you can uderstand why I am so vociferous in my criticism of this company.  I have been around long enough to have seen that NR.  I have bought and sold many stocks over time but never have I seen such a load of nonsense on an on going basis.  I have documented in my last post the sillyness of how this deal has been dealt with.  If you really want to ...more  
Comment by psvbruceleefc on Jan 21, 2021 2:53pm
Your patience must be waring very thin, do u see any light at the end of the tunnel or do u see this just rolling on and on ? 
Comment by Ingiboy on Jan 22, 2021 5:33pm
My patience is gone completely.   Questions: Do you see any ight at the end of the tunnel ? No Do you see this rolling on and on ?  Yes
Comment by psvbruceleefc on Jan 22, 2021 5:50pm
Someone on Twitter is holding them to account will be interesting to see if a response comes 
Comment by lscfa on Jan 22, 2021 9:10pm
anyone know if the Replicel CEO is full time? The CEO at SBM is an emergency room physician and the lack of company progress shows. Maybe the same damn thing here too.
Comment by Ingiboy on Jan 22, 2021 9:54pm
No the CEO of Replicel is a full time employee. I am going to cut him some slack.  I think the holdup is not Replicel's fault other than convincing Mainpointe to get their shite together and get this done.   I am beginning to think that Mainpointe has thrown Replicel a curve ball.  They possibly have or are trying to change the deal from the first draft. They may be wanting to ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities